HNF4A and metabolic syndrome: Biochemical assessment of HNF4A-null mice demonstrated that reduced HNF4A activity cause dyslipidemia through decreased circulating lipid levels and altered HDL composition, which resulted from the disruption of TG and TC secretion from the liver (35), albeit the lipid profile of the reported families with HNF4A-MODY varies considerably (39, 40).